The molecular mechanisms whereby volatile general anesthetics (VAs) disrupt behavior remain undefined. In Caenorhabditis elegans mutations in the gene unc-64, which encodes the presynaptic protein syntaxin 1A, produce large allele-specific differences in VA sensitivity. UNC-64 syntaxin normally functions to mediate fusion of neurotransmitter vesicles with the presynaptic membrane. The precise role of syntaxin in the VA mechanism is as yet unclear, but a variety of results suggests that a protein interacting with syntaxin to regulate neurotransmitter release is essential for VA action in C. elegans. To identify additional proteins that function with syntaxin to control neurotransmitter release and VA action, we screened for suppressors of the phenotypes produced by unc-64 reduction of function. Loss-of-function mutations in slo-1, which encodes a Ca 2ϩ -activated K ϩ channel, and in unc-43, which encodes CaM-kinase II, and a gainof-function mutation in egl-30, which encodes Gq␣, were isolated as syntaxin suppressors. The slo-1 and egl-30 mutations conferred resistance to VAs, but unc-43 mutations did not. The effects of slo-1 and egl-30 on VA sensitivity can be explained by their actions upstream or parallel to syntaxin to increase the level of excitatory neurotransmitter release. These results strengthen the link between transmitter release and VA action.
D ESPITE longstanding efforts, volatile anesthetic
animal. Screens in Drosophila have isolated mutant stains that are modestly VA resistant to some anesthetic (VA) mechanisms remain undefined. At a cellular level, the synapse is generally accepted as the site of endpoints (Krishnan and Nash 1990; Tinklenberg et al. 1991; Leibovitch et al. 1995; Gamo et al. 2003) ; action (Pocock and Richards 1991; Franks and Lieb 1994) . In vertebrate nervous systems, both presynaptic however, highly resistant mutants have not been uncovered. (Zorychta and Capek 1978; Takenoshita and Takahashi 1987; Kullmann et al. 1989; Miao et al. 1995;  In Caenorhabditis elegans, two sorts of approaches have been taken. Using supraclinical concentrations of VAs Perouansky et al. 1995; Schlame and Hemmings 1995; MacIver et al. 1996; Nishikawa and MacIver 2000) to produce immobilization as an anesthetic endpoint, and postsynaptic anesthetic effects ( Jones et al. 1992;  Morgan, Sedensky, and co-workers have isolated novel Mihic et al. 1997; Patel et al. 1999; Yamakura et al. 2001) mutants that are VA hypersensitive or that are suppreshave been observed that might contribute to a state of sors of the VA-hypersensitive phenotype (Morgan and general anesthesia. However, establishing a causal link Cascorbi 1985; Sedensky and Meneely 1987; Morgan between VA effects in vitro and in vivo has been problemet al. 1988; Morgan et al. 1990 ; Morgan and Sedensky atic. Genetics is one approach for making such a link. 1994). One of the mutations producing VA hypersensiFor example, a point mutation in the ␤3 subunit of the tivity was found to lie in the gene gas-1, which encodes GABA A receptor eliminates the action of the intravethe 49-kD subunit of mitochondrial NADH:ubiquinonenously administered general anesthetics etomidate and oxidoreductase (complex I of the respiratory chain). Suppropofol against response to a painful stimulus in a pressors of the hypersensitivity were found among mutamouse knockin strain (Jurd et al. 2003) . Thus, genes. unc-1 ention of GABA A receptors is the major relevant action codes a stomatin homolog (Rajaram et al. 1998) ; unc-8 for these anesthetics. However, for VAs, no mutations encodes an epithelial sodium channel (Tavernarakis et of a vertebrate gene have resulted in a highly resistant al. 1997); unc-7 and unc-9 encode innexins, which are thought to be structural components of invertebrate gap junctions (Starich et al. 1996 ; Barnes and Hekimi gas-1 and the other genes producing VA hypersensitivity regulate VA action on transmitter release is required to define the VA mechanism. Reduction-of-function mutamay directly or indirectly sensitize to VA immobilization through a mechanism requiring gap junctions. Alleletions exist in some of these syntaxin interactors; however, they generally produce severe behavioral deficits specific interactions between unc-1 and unc-8 also suggest the possibility that these gene products interact and that preclude testing of their VA sensitivity. To circumvent this problem, here we test the VA sensitivity of form a complex that regulates the binding or activity of VAs at supraclinical concentrations (Rajaram et al. mutations isolated in a screen for enhancers of transmitter release. The screen was performed in the back-1999).
At lower concentrations similar to those used for huground of a syntaxin reduction-of-function mutation. The syntaxin mutant background facilitated screening man anesthesia, VAs do not immobilize C. elegans; rather their locomotion becomes uncoordinated and sluggish and potentially enriched for mutations that directly enhance syntaxin function. Analysis of the synaptic but (Crowder et al. 1996) . Mutations in genes that alter neurotransmitter release in C. elegans have been found not the anesthetic phenotypes of mutations in one of the genes identified in this screen was reported in Wang to control these VA behavioral effects (van Swinderen et al. 1999 (van Swinderen et al. , 2001 (van Swinderen et al. , 2002 . These mutations do not alter et al. (2001) . sensitivity to supraclinical VA concentrations in the immobilization assay (Humphrey et al. 2002) et al. 1989; Miao et al. 1995;  and from our own mutagenesis screens as described below. Perouansky et al. 1995; Schlame and Hemmings 1995;  All strains were grown on nematode growth media (NGM) MacIver et al. 1996; Nishikawa and Kidokoro 1999;  agar seeded with OP50 bacteria (Brenner 1974 transmitter release, an action that could be responsible for at least some behavioral effects of anesthetics. In tg26, n686), .
LGII: bli-2(e768).
support of this hypothesis, some VA-resistant mutants in LGIII: dpy-19(e1259), unc-64(e246, md130, js21). C. elegans and Drosophila antagonize the effect of VAs on js383, e755). acetylcholine and glutamate release, respectively (Nishi-PS2284: dpy-20(e1282); syEx125[pMH86ϩpLB2ϩpBS] (Brundage kawa and Kidokoro 1999; van Swinderen et al. 1999 van Swinderen et al. ). et al. 1996 . PS2284 is referred to in the text as Ex[Gq(ϩ)].
The presumptive presynaptic VA target(s) in C. elegans pMH86 contains a full-length genomic clone of dpy-20(ϩ), which rescues dpy-20(e1282), inserted into pBluescript SK ϩ is unknown. Direct screens for high-level VA resistance and as such was used as a transformation marker; pLB2 have been difficult and thus far unsuccessful. However, contains a full-length egl-30(ϩ) genomic clone inserted into testing of existing C. elegans mutants found that mutapBluescript SK ϩ (pBS; Brundage et al. 1996) .
tions in unc-64, which encodes the presynaptic protein PS2554 is referred to in the text as GqHS (Q205L) ϭ dpysyntaxin 1A, produced large allele-specific differences 1995) . pLB24 was injected at 50 ng/l along with pMH86 1999). Syntaxin 1A is an integral membrane protein and pBS, and the resultant array was integrated with a 38-Gy X-ray source and outcrossed eight times (C. Bastiani, L.
that interacts with SNAP-25 and synaptobrevin (VAMP), Brundage and P. Sternberg, personal communication tic membrane (Chen and Scheller 2001) . Multiple
LGV : slo-1(js100, js118, js379, js380, js381, js382, eg24, eg161, other proteins function along with syntaxin and the eg73) dpy-11(e224), egl-8(n488), unc-34(e566), unc-60(e677), dpy-11(e224 III, sis that a protein physically interacting with syntaxin is IV; egl-30(js126);unc-64(md130), egl-30(js126);unc-64 is not the target but is essential for the action of VAs egl-30(js126);dgk-1(nu199), and egl-30(js126);egl-8(n488) .
on their target. In either case, identification of this hy- , and egl-30(js126);dgk-1(nu199), dpy-5(e61) was used as a visible pothesized protein and more generally proteins that marker in cis with egl-30(js126). egl-30(js126) dpy-5(e61) /ϩ males aries was sequenced and was found to have a single mutation, a G-to-A transition, resulting in a valine to methionine at were crossed into unc-64(md130), unc-64(js21), and dgk-1 (nu199 In 53 of 53 independent recombinants, the loopy locomotion, the aldicarb-hypersensitive, and the VA-resistance phenotypes semidominant weak loopy phenotype were picked singly to plates and strong loopy F 2 animals were chosen from plates cosegregated. unc-43 alleles: js125 and js383 failed to complement for supthat segregated the balancer phenotypes. F 3 animals not segregating the balancer were presumed to be the double mutant.
pression of the aldicarb-resistance phenotype of unc-64(e246). The Sup phenotype of js125 was placed onto chromosome IV Genotypes of all double mutants were confirmed by outcrossing and segregation of both mutant phenotypes and by seon the basis of limited recombination with dpy-13. Only 5/ 49 animals of the genotype unc-64(e246); dpy-13 ϩ/ϩ js125 quencing egl-30 to confirm homozygosity of the js126 mutation.
segregated Dpy Unc Sup progeny placing js125 near dpy-13. Both j125 and js383 were noted to exhibit a shrinker phenoMutagenesis screen for suppressors of unc-64(rf ): unc-64 (e246rf) L4 larvae were exposed to 50 mm EMS in M9 buffer type, the simultaneous contraction of all four body-wall muscle quadrants in response to anterior touch, which is characteristic for 4 hr with agitation and then washed three times with M9. The F 2 progeny were screened visually for improved locomoof reduced GABAergic neurotransmission (McIntire et al. 1993) . Two genes that when mutated produced the shrinker tion compared to unc-64(e246). Progeny of putative suppressor mutants were similarly screened and one animal that clearly phenotype were within the mapped interval, so complementation was performed with both. js125 fully complemented the moved better than e246 was kept to establish each strain. Overall, 24,000 genomes were screened and 14 confirmed shrinker phenotype of unc-30(e191) but failed to complement unc-43(e408). The unc-43 coding region along with exon/insuppressors were isolated. Each suppressor strain was outcrossed against N2 at least three times and outcrossed strains tron boundaries was sequenced in js383 and G-to-A transition in the slice acceptor site before exon 15 was found. In js125, with and without e246 in the background were kept for further characterization. Suppressor mutations crossed out of the e246 a 17-kb region extending from 10 kb upstream of the transcription initiation site through exon 10 was refractory to PCR background were examined for behavioral, morphological, anesthetic-sensitivity, and aldicarb-sensitivity phenotypes (see amplification, indicative of a deletion of this region. Behavioral assays: All assays were performed at room tembelow). Any additional phenotypes of the suppressor mutations after outcrossing were confirmed to cosegregate with perature (22Њ-23Њ) on young adults. Two assays were used to quantify locomotion. suppression of e246.
Genetic characterization and mapping: Prior to mapping, Velocity assays: The speed of spontaneous and stimulated movement was measured by digital video imaging. One-day mutants were analyzed for dominance of their phenotypes and, if recessive, were placed into complementation groups on post-L4 young adults were picked onto plates seeded with OP50 Escherichia coli. Movies (60 sec) of single animals were the basis of their suppression of unc-64(e246). Of the mutations presented here, only js126 exhibited dominant phenotypes.
taken immediately before and immediately after dropping a weight from a fixed height onto the lid of the Petri dish. The The mutations fell into at least five complementation groups; representatives from three complementation groups are anaaverage forward movement of the midbody in each 1-sec frame was measured. For each strain, Ͼ20 animals were assayed to lyzed in this report. For placement of mutant loci onto chromosomes, the following visible marker mutations were used: calculate the speed (micrometers per second) for that strain. Body bend assays: The body bend assay was used to measure dpy-5(e61) I; bli-2(e768) and rol-6(e187) II; and lon-1 (e185) III; dpy-19(e1259) and bli-6(sc16) IV, dpy-11(e224) and the VA sensitivity of strains. Without transferring bacteria (either by transferring first to an unseeded plate or by picking unc-23(e324) V, and lon-2(e678) X. The general method was to cross homozygous or heterozygous test mutant males into animals that were off of the bacterial lawn), young adults were transferred via platinum wire to an unseeded NGM plate. After the mapping strain and then pick F 2 progeny expressing the phenotype(s) of the test mutant [e.g., loopy, aldicarb hypersena 29-min incubation period, the plate was vigorously shaken (inside a clear glass chamber containing volatile anesthetic; sitivity, or suppression of unc-64 (246)]. The F 3 progeny were scored for the marker phenotype and homozygosity of the see below) for ‫5ف‬ sec. After one more minute, body bends were counted for 2 min. One body bend consisted of a comtest mutation.
slo-1 alleles: Genetic characterization, mapping, and identiplete period of the waveform in the nematode's forward sinusoidal motion. Backward body bends were not counted. The fication of the six slo-1 mutants isolated in this screen (js100, js118, js379, js380, js381, and js382) were described previously body bends of at least 10 animals were counted per strain and condition. (Wang et al. 2001) .
egl-30(js126): For mapping of e246 suppression by js126, Heat-shock experiments: Young adult animals on agar plates were placed at 30Њ for 4 hr. Then, the body bend assay was males with the genotype e246/ϩ;marker/ϩ were crossed with js126;e246 and the brood of suppressor ;e246 animals was performed as described above. Non-heat-shock controls were kept at 20Њ during the heat-shock incubation. scored for frequency of marker segregation. Twelve of 51 Unc Sup animals produced Dpy progeny, indicating loose linkage Drug assays: Volatile anesthetics: After transfer of animals to assay plates, the plates were placed immediately into small of js126 to dpy-5 on chromosome I. szT1 balances the left arm of chromosome I and was found to balance the js126 dpy-5 glass chambers as previously described (Morgan and Cascorbi 1985; Crowder et al. 1996) . The chambers were sealed interval. Candidate genes within this interval consistent with the map distance from dpy-5 included egl-30. Overexpression except for a small sideport and a measured volume of anesthetic in its liquid phase was deposited through the sideport onto of egl-30 had been shown to exhibit loopy locomotion similar to js126 (Brundage et al. 1996) . The entire egl-30 coding the roof of each chamber using a Hamilton syringe and the sideport was quickly sealed. The anesthetic completely volatilregion in js126 genomic DNA including exon/intron bound-izes within 30 sec and produces a steady-state behavioral effect concentrations in the chambers were measured by gas chromatography and expressed as volume % (vol%). The predicted within 10 min. The volume of anesthetic placed in the chamber was calculated to produce a desired gas phase concentraand actual concentrations typically differed by Ͻ10%. The measured VA concentrations were plotted against the body tion according to the ideal gas equation given the volume of the chamber and the density and molecular weight of the bends per minute using the sigmoidal equation
) Ϫk ) where y is the body bends per liquid anesthetic. At the end of each assay, the actual VA minute, x is the [VA] concentration in vol%, max is the body bend assay in the presence and absence of VA was performed bends per minute with no VA added, min is the body bends as described above. per minute where it is at the lowest (i.e., at the highest VA concentrations), x 50 is the EC 50 (VA concentration at which the body bends per minute is half maximal), and k is the slope RESULTS of the curve. The EC 50 's were used as the measure of VA sensitivity. A minimum of 10 points was used to generate each Isolation and characterization of suppressors of synconcentration/response curve. The VA sensitivities of strains taxin reduction-of-function mutants: We performed a muwere statistically compared by simultaneous curve fitting tagenesis screen in C. elegans for mutations suppressing the (Waud 1972; DeLean et al. 1978) .
aldicarb-resistance and lethargic locomotion phenotype Loss of slo-1 function confers VA resistance: As preArecoline assay: The VA sensitivity of animals was measured viously reported, the largest complementation group on plates containing the muscarinic agonist arecoline hydroisolated in our screen consisted of loss-of-function mutabromide (Avery 1993; Lackner et al. 1999) . A sterile 142 mg/ml arecoline stock solution was made and stored at 4Њ; tions in the slo-1 locus, which codes for a calcium-acti-167 l of a sterile 142 mg/ml arecoline solution in water was vated potassium channel (BK channel) negatively reguadded to the surface of freshly poured unseeded 10-ml NGM lating the duration of transmitter release in C. elegans plates to produce a concentration of 2.4 mg/ml. Then, a (Wang et al. 2001) . After outcrossing the suppressor fraction of the plates were seeded with OP50. Test animals mutations away from unc-64(e246), all slo-1(lf) alleles were incubated on the seeded arecoline plates for 30 min and then transferred to an unseeded arecoline plate and a body tested were found to be resistant to the VA halothane (Brundage et al. 1996) . All values are expressed as mean ϮSEM. ( Figure 2, A and D) . slo-1(lf) mutations have also been . While supraclinical concentrations of VAs have been shown to inhibit vertebrate SLO-1 isolated in a screen for resistance to ethanol . Three slo-1 alleles isolated in this screen (eg24, orthologs, clinical concentrations of VAs have little effect (Pancrazio et al. 1993; Hong et al. 1994) . Moreover, eg161, and eg73) were tested for VA sensitivity. All three were resistant to halothane ( Figure 2D ). Loss of slo-1 to inhibit transmitter release, VAs would be predicted to augment the SLO-1 channel as ethanol does. function has been shown to enhance cholinergic neurotransmission through a prolongation of acetylcholine Loss of unc-43 function suppresses syntaxin reduction of function without producing VA resistance: js125 and transmitter release at C. elegans motor neuron synaptic terminals (Wang et al. 2001) . Although SLO-1 could js383 formed a second complementation group of unc-64 (rf) suppressors. When outcrossed from unc-64(e246), be a direct target of VAs, the VA resistance of slo-1(lf) mutants can be explained by an indirect antagonism both mutants were found to have VA sensitivities not significantly different from those of wild type (Figure of the reduction in excitatory neurotransmitter release produced by VAs. Resistance to ethanol, however, does 2, B and D). js125 and js383 were also behaviorally quite distinct from the other suppressor mutants. While the not appear to be the indirect consequence of an alteration in the level of transmitter release; rather, ethanol other suppressors outcrossed from e246 moved in a hyperactive manner, both js125 and js383 moved sluggishly was shown to directly potentiate the SLO-1 channel and exhibited a shrinker phenotype, the simultaneous thought to produce a gain of function (Doi and Iwasaki 2002) , showed that this allele also suppressed unccontraction of all four body-wall muscle quadrants in response to touch. Shrinking is a relatively uncommon 64(e246), increasing its mean velocity nearly fourfold (data not shown), and was VA resistant ( Figure 2D ). eglmutant phenotype, found in strains with reduced GABAergic neurotransmission (McIntire et al. 1993) and 30(n686), a weak reduction-of-function allele, was halothane hypersensitive (EC 50 ϭ 0.178 Ϯ 0.047 vol%). On in mutants in the unc-43 gene, which lie within the genetic interval to which js125 mapped. unc-43 encodes calcium/ the basis of these data, we conclude that js126 produces a gain of function in egl-30, which antagonizes VA action. calmodulin-dependent protein kinase II (CaM-kinase II; Reiner et al. 1999; Rongo and Kaplan 1999) . Sequencing Both js126 and tg26 could produce a novel activity not normally present in the wild-type egl-30 product. To of unc-43 revealed mutations in both js125 and j383. js125 deletes the first 10 exons of unc-43; js383 had a G-to-A test whether wild-type egl-30 antagonizes VA activity, we measured the VA sensitivity of a strain overexpressing transition in the splice acceptor prior to exon 15 (see materials and methods). Thus, js125 likely produces wild-type egl-30 (Brundage et al. 1996; Lackner et al. 1999) . Animals transformed with extra copies of egla complete loss of function of unc-43. Gain-of-function and loss-of-function unc-43 alleles have been isolated 30(ϩ) were significantly halothane resistant with EC 50 's greater than twofold that of wild-type animals (Figure previously (Reiner et al. 1999) . As expected given that the mutation deletes a large portion of the coding se-3B). Similarly, heat shock of animals transformed with a GTPase-defective egl-30 transgene fused to a heat-shockquence, js125 resembled unc-43(e755), a previously isolated severe loss-of-function mutant. js125 and e755 as inducible promoter (Lackner et al. 1999 ) resulted in an even higher level of halothane resistance (Figure well as js383 are sluggish, shrinkers, and aldicarb hypersensitive (Reiner et al. 1999; Robatzek and Thomas 2000; 3C) . To confirm that the transformed genes were conferring a gain of egl-30 function, aldicarb sensitivity was Figures 1E and 2B) . unc-43(gf) alleles do not shrink and are aldicarb resistant (Robatzek and Thomas 2000) . measured, and as expected both strains were aldicarb hypersensitive ( Figure 3D ). These data are consistent unc-43(e755) but not unc-43(gf) alleles suppressed the phenotypes of unc-64(rf) (data not shown). Thus, we with antagonism of VAs by the wild-type activity of EGL-30 and argue against the hypothesis that the js126 mutaconclude that both js125 and js383 are loss-of-function alleles of unc-43 and that unc-43 negatively regulates tion produces a novel function not normally present in egl-30. syntaxin function but not VA action.
Gq␣ signaling antagonizes VA action: Unlike the slo-1 Pathway for EGL-30's regulation of VA sensitivity: To begin to define the pathway whereby EGL-30 regulates and unc-43 mutants, the js126 mutation produced dominant phenotypes, including loopy hyperactive locomo-VA sensitivity, we measured the effect of drugs previously shown to activate the EGL-30 signaling pathway. The tion, aldicarb hypersensitivity, and VA resistance (Figures 1F and 2, C and D) . The syntaxin suppressor muscarinic acetylcholine agonist, arecoline, produces hypercontraction of the C. elegans pharynx and aldicarb phenotype of js126 mapped to a region containing the egl-30 gene (see materials and methods), which enhypersensitivity, both effects of which are suppressed by egl-30(rf) (Brundage et al. 1996; Lackner et al. 1999) . codes the ␣-subunit of the G protein Gq shown to positively regulate locomotion, feeding, egg laying, and choThese results have led to a model where muscarinic receptors are coupled to EGL-30 and activation of muslinergic neurotransmission (Brundage et al. 1996) . Sequencing of js126 identified a mutation in egl-30, a carinic receptors stimulates EGL-30, which positively regulates acetylcholine release (Brundage et al. 1996 ; G-to-A transition, resulting in a valine-to-methionine substitution at position 180 of EGL-30. While valine 180 Lackner et al. 1999) . If the muscarinic receptor is coupled to EGL-30 in the cells where VAs act, then activation has not itself been directly implicated in Gq␣ function, this region in vertebrate orthologs has been shown to of muscarinic receptors should antagonize VAs. Indeed, the muscarinic agonist arecoline produced halothane bind to the ␥-phosphate of GTP and ADP-ribosylation of the adjacent arginine 179 inhibits GTPase activity (Noel resistance ( Figure 4A ). Downstream of EGL-30, phorbol esters augment acetylcholine release from C. elegans moet al. 1993) . Thus, a reasonable hypothesis to explain the phenotype of js126 is alteration of GTPase activity.
tor neurons (Lackner et al. 1999; Miller et al. 1999) . Both genetic and biochemical evidence implicate UNCIndeed, expression of a GTPase-defective EGL-30 results in animals with loopy hyperactive locomotion, constitu-13 as the phorbol ester receptor acting downstream of EGL-30 to enhance acetylcholine release (Maruyama tive egg laying, and aldicarb hypersensitivity similar to the phenotypes of js126 (Brundage et al. 1996; Lackner and Brenner 1991; Ahmed et al. 1992; Lackner et al. 1999) . Moreover, UNC-13 has been shown to interact with et al. 1999). On the other hand, egl-30 reductionof-function mutants such as n686 ( Figure 1F ) are slugthe N terminus of syntaxin, making this pathway an attractive candidate for modulation of VA sensitivity by gish and aldicarb resistant (Brundage et al. 1996; Lackner et al. 1999; Miller et al. 1999) . Thus, js126 behaves syntaxin mutants (Betz et al. 1998) . Indeed, phorbol ester-treated animals were significantly resistant to haloas an egl-30(gf) allele and not as an egl-30(lf) allele. Testing of egl-30(tg26), a behaviorally similar egl-30 allele thane ( Figure 4B ). Gq(ϩ) ] is a genomic egl-30 fragment including the native promoter, the entire coding sequence, and 3Ј noncoding sequence (Brundage et al. 1996) . In GqHS (Q205L) , the native promoter was replaced with the hsp-16-2 heat-shock-inducible promoter and the codon for aspartate 205 was mutated to produce a lysine. The Q205L lesion is predicted to disrupt the GTPase activity of EGL-30, producing a constitutively active protein. (B) Halothane sensitivity of animals transformed with Ex[Gq(ϩ)] compared to N2. The rate of body bends was measured for each animal over a 2-min period. Each data point represents the mean ϮSEM of at least 10 animals. EC 50 of Ex[Gq(ϩ)] was greater than that of N2, P Ͻ 0.01 by simultaneous nonlinear regression. (C) Comparison of halothane EC 50 's of egl-30 gain-of-function strains. A 4-hr heatshock induction was performed on adult animals just prior to anesthetic testing. *P Ͻ 0.05 compared to N2 by simultaneous nonlinear regression (Waud 1972; DeLean et al. 1978) . (D) Comparison of aldicarb sensitivity of egl-30 gain-of-function strains. Animals were incubated on plates containing 0.1 mm aldicarb for 4 hr and then the fraction of animals that moved over the next hour was scored as the movement index. Heat-shock induction was performed on adult animals just prior to anesthetic testing. *P Ͻ 0.05 compared to N2 two-tailed test; † P Ͻ 0.05 compared to non-heat-shocked control.
To define genetically the pathway whereby egl-30 reguwas normally sensitive to halothane, indicating that VAs act downstream of or parallel to EGL-8. lates volatile anesthetics, we tested strains carrying mutations in genes previously shown to lie downstream of Diacylglycerol (DAG) is a major product of PLC␤ and positively regulates excitatory neurotransmission in egl-30 in its regulation of transmitter release. Modulation of neuromuscular transmission by egl-30 requires, at vertebrates (Brose et al. 2000) and in C. elegans (Lackner et al. 1999; Miller et al. 1999) . Diacylglycerol kinase least in part, the activity of egl-8 (Lackner et al. 1999; Miller et al. 1999) . egl-8 encodes a phospholipase C␤ inactivates DAG by converting it to phosphatidic acid. If EGL-30 regulates VA sensitivity through accumulation homolog that positively regulates neuromuscular synaptic transmission (Lackner et al. 1999; Miller et al. 1999) .
of DAG, loss-of-function mutations in dgk-1, which encodes a C. elegans diacylglycerol kinase that inactivates egl-8(lf) fully suppressed the VA-resistance, aldicarb-resistance, and hyperlocomotion phenotypes of egl-30(js126) DAG (Lackner et al. 1999; Miller et al. 1999; Nurrish et al. 1999) , should be VA resistant. dgk-1(nu199lf) was (Table 1) . Thus, as for locomotion and transmitter release, we conclude that EGL-30 regulates VA sensitivity by stimuhalothane resistant at a level similar to egl-30(js126) (Table 1). The double mutant combination of dgk-1(nu199) lating EGL-8 PLC␤ activity. However, egl-8(n488lf) itself and egl-30(js126) was not significantly more resistant presumably reflects an action of anesthetics on locomotion that is measured by the dispersal but not body than either single mutant. This lack of additivity is consistent with egl-30 acting exclusively through DAG to bends assay and that is not effectively antagonized by dgk-1(lf). Nevertheless, VA resistance in the body bends regulate VA sensitivity. Notably, in a different locomotion assay (the dispersal assay) where the task requires assay does demonstrate that dgk-1 regulates at least some components of VA action on the neurons controlling moving a fixed distance within the assay period, dgk-1 (lf) mutants are not VA resistant (van Swinderen et al. locomotion and is consistent with egl-30 antagonizing this VA action. 2001). The different results in the two types of assays The final mediators of synaptic vesicle fusion and were not the nonspecific drugs that many had proposed but in fact their action could be blocked by mutation neurotransmitter release are thought to be the SNARE proteins, syntaxin, SNAP-25, and VAMP. To examine of a single gene and, second, that at least in C. elegans the relevant anesthetic target was likely a molecule that whether EGL-30 acts through syntaxin to regulate VA sensitivity, we tested the VA sensitivity of egl-30(js126) in interacted with or is regulated by the syntaxin. The experiments reported here were designed to better unthe presence of two different unc-64 syntaxin mutations. unc-64(md130) has a mutation in the splice donor site derstand syntaxin's role in anesthetic action and potentially identify the putative anesthetic target interacting of the sixth intron (Saifee et al. 1998) , resulting in the synthesis of truncated syntaxin products and a reduced with syntaxin. Suppressors of syntaxin reduction of function were amount of full-length product. The reduced level of syntaxin is responsible for all of the syntaxin reductionexpected to fall into one of three classes. First, informational tRNA suppressor mutations could revert the muof-function phenotypes; the truncated products confer VA resistance. unc-64(js21) carries a missense mutation tation in the e246 protein. However, none of the identified suppressors fall into this class. A second class would that simply reduces syntaxin function (Saifee et al. 1998) and like other mutants, with the exception of be composed of mutations in proteins that complex with syntaxin and suppress e246 by having complementary unc-64(md130), with reduced transmitter release is VA hypersensitive. double mutations in residues involved in interaction with the mutated syntaxin. The e246 mutation substitutes a valine mutant was more halothane resistant than js126 but not significantly different from md130. However, the for alanine at position 248 of syntaxin (Saifee et al. 1998 ). This residue has been shown by crystallography aldicarb resistance of md130 was significantly reduced by js126, indicating that egl-30 can still positively regulate and electron spin resonance studies to lie on the hydrophobic face of the H3 helical domain of syntaxintransmitter release in the presence of the md130 mutation. Given that md130 is a reduction-of-function but 1A when in a complex with itself and SNAP-25 (a t-SNARE complex) or with VAMP and SNAP-25 (the not null mutation in syntaxin, the ability of js126 to augment transmitter release in md130 is not surprising.
final ternary SNARE complex; Poirier et al. 1998; Sutton et al. 1998; Xiao et al. 2001 ; Brunger and Ernst The lack of additivity of the VA resistances of js126 and md130 is more informative and suggests that the effect 2002). Thus, mutations in complementary residues in SNAP-25 and/or VAMP might restore function in e246 of the md130 mutation on VA sensitivity is not modulated by the output of EGL-30 and is not dependent on mutated syntaxin. Besides SNAP-25 and VAMP, several additional proteins have been shown to interact with the general level of cholinergic transmission. In contrast, the anesthetic phenotype of the js126; unc-64(js21) syntaxin in the H3 domain (Rizo and Sudhof 2002) ; however, unlike the SNARE complex components, it is double mutant resembled the js126 single mutant and not js21; however, the aldicarb and locomotion phenounclear if valine 248 interacts with or is required for the interaction with these proteins. In any case, this sort types are intermediate between that of the single mutants. Thus, neither hyperactivity nor increased levels of complementing protein suppressor mutant would act allele specifically. None of the suppressor mutations act of synaptic acetylcholine are essential for the VA resistance of js126. The genetic interactions between unc-64 on only specific syntaxin alleles; each increases cholinergic neurotransmission of the wild-type syntaxin allele and egl-30(gf) with respect to locomotion, aldicarb, and VA sensitivities are identical to those between unc-64 and at least one unc-64(rf) allele. In addition, none of the suppressor genes encode known syntaxin-interand goa-1(lf), which encode a C. elegans Go␣ homolog (van Swinderen et al. 2001) . These results are consisacting proteins. Therefore, the isolated suppressor mutants are unlikely to belong to this second class of suptent with goa-1 acting antagonistically to EGL-30 to regulate cholinergic neurotransmitter release and VA sensipressors. The third class of suppressors could act by enhancing tivity (Hajdu-Cronin et al. 1999; Lackner et al. 1999; Miller et al. 1999; Chase et al. 2001; cholinergic neurotransmission regardless of the nature of the syntaxin allele. On the basis of the aldicarb-hyper-2001; van der Linden et al. 2001; van Swinderen et al. 2001) .
sensitive phenotype of the suppressor mutants in a wildtype syntaxin background, each suppressor appears to fall into this category. Indeed, in the case of slo-1, direct DISCUSSION electrophysiological evidence demonstrates that slo-1 (lf) enhances acetylcholine release (Wang et al. 2001) , Our previously reported results have shown that a truncated syntaxin produced by an intron splice donor and selective expression of SLO-1 shows that it controls cholinergic neurotransmission by acting in neurons not site mutation in unc-64(md130) is capable of completely antagonizing the effects of clinical concentrations of muscle. Thus, SLO-1 acts presynaptically to inhibit transmitter release. The role of EGL-30 in transmitter release volatile anesthetics on C. elegans locomotion (van Swinderen et al. 1999) . This remarkable finding suggested has not been confirmed by electrophysiological methods. However, genetic and pharmacological data pretwo important conclusions: first, that volatile anesthetics sented here and elsewhere indicate that EGL-30 acts in LITERATURE CITED motor neurons by activating phospholipase C␤, producAhmed, S., I. N. Maruyama, R. Kozma, J. Lee, S. Brenner et al., 1992 ing DAG, which directly activates UNC-13, a syntaxin
The Caenorhabditis elegans unc-13 gene product is a phospholipiddependent high-affinity phorbol ester receptor. Biochem. J. 287: binding protein (Lackner et al. 1999; Miller et al. 1999;  995-999. Brose et al. 2000) .
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Among the suppressor mutants, the unc-43(lf) alleles
